This company listing is no longer active
PC5 Stock Overview
Provides agricultural biological products and technology solutions in the United Kingdom, the United States, Mexico, Spain, and Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Plant Health Care plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.10 |
| 52 Week High | UK£0.10 |
| 52 Week Low | UK£0.028 |
| Beta | 0.81 |
| 11 Month Change | 0% |
| 3 Month Change | 53.38% |
| 1 Year Change | 3.03% |
| 33 Year Change | -17.07% |
| 5 Year Change | 54.55% |
| Change since IPO | -36.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| PC5 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 1.0% | -0.1% | 1.3% |
| 1Y | 3.0% | -0.3% | 7.9% |
Return vs Industry: PC5 exceeded the German Chemicals industry which returned -0.7% over the past year.
Return vs Market: PC5 matched the German Market which returned 3.8% over the past year.
Price Volatility
| PC5 volatility | |
|---|---|
| PC5 Average Weekly Movement | 16.3% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PC5's share price has been volatile over the past 3 months.
Volatility Over Time: PC5's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 55 | Jeff Tweedy | www.planthealthcare.com |
Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the United Kingdom, the United States, Mexico, Spain, and Brazil. It operates through Commercial – Americas; Commercial – Mexico; Commercial – Rest of World; and Plant Response Elicitor Technology (PREtec) segments. The company offers Harpin aß, a recombinant protein, which acts as a biostimulant to enhance the quality, nutrient use, tolerance to abiotic stress, and yield quality of crops; Saori, a vaccine for plants that promotes healthy growth of soybeans and helps them fight disease; and Obrana, a foliar product to help growers control a range of fungal and bacterial plant pathogens within fruits, nuts, vegetables, and row crops.
Plant Health Care plc Fundamentals Summary
| PC5 fundamental statistics | |
|---|---|
| Market cap | €35.74m |
| Earnings (TTM) | -€3.60m |
| Revenue (TTM) | €10.07m |
3.5x
P/S Ratio-9.9x
P/E RatioIs PC5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PC5 income statement (TTM) | |
|---|---|
| Revenue | US$11.21m |
| Cost of Revenue | US$4.44m |
| Gross Profit | US$6.77m |
| Other Expenses | US$10.77m |
| Earnings | -US$4.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 60.37% |
| Net Profit Margin | -35.70% |
| Debt/Equity Ratio | 4.7% |
How did PC5 perform over the long term?
See historical performance and comparison